ReviewCancers2021

Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers.

Raffaele Di Francia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.